SXTC · Company research
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.25 | $101,063.66 | -28074801.3424 | — | — | — | — | 0.00785861149446087917 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.